Clinical Trials Browser

Rectal Neoplasms

Uterine Cervical Neoplasms, Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Adenocarcinoma, Carcinoma, Rectal Neoplasms, Colorectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms, Anastomotic Leak

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Pathologic Complete Response, Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms, Urinary Retention

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Low Anterior Resection Syndrome, Intestinal Diseases, Rectal Neoplasms

Rectal Neoplasms

Rectal Diseases, Rectal Neoplasms, Sigmoid Diseases, Sigmoid Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms, Thrombosis

Rectal Neoplasms

Gastrointestinal Neoplasms, Rectal Neoplasms

Low Anterior Resection Syndrome, Rectal Neoplasms

Low Anterior Resection Syndrome, Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Clinical Trials

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial

ART-Hypo

BIOREC

Neoadjuvant Short-course Radiotherapy Followed by a Combination of Disitamab Vedotin, Sintilimab, and Capecitabine in Locally Advanced HER2-expressing Rectal Cance

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

The Application of a Novel Endoluminal Robotic System for Colorectal Endoscopic Submucosal Dissection

NG-ST

RELOAD

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

ColoSeal™ ICD System Anastomotic Protection Pivotal Study

RECTIL

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in High-Risk Locally Advanced Rectal Cancer

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

A Phase II Prospective Study of Maastro Applicator Brachytherapy for Rectal Cancer

PKUCH- R11

Neoadjuvant mFOLFOX6 Chemotherapy Combined With Anti-PD-1 Therapy in MSS/pMMR Locally Advanced Rectal Cancer (FIRM02 Study)

Autologous Probiotics in Patients With Defunctioning Ileostomy Following LAR for Rectal Cancer

ULTIMATE

Effect of Individualized Catheter Management on Early Removal After Rectal Cancer Surgery

INJECTABL-3

Preventive Efficacy of Bergmann Enema for Acute Radiation-induced Rectal Injury in Rectal Cancer Patients Undergoing Short-course Radiotherapy

SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

SHOOL

BFT in LARS

BCMRECRAD

ExPeTuD

A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

ESISD vs CESD

REACT

Family Communications After Genetic Testing

QL1706 With Short-Course Radiotherapy and Chemotherapy for MSS Rectal Cancer

REFIRT

STAR

Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer

Magnetic Resonance Imaging (MRI)-Guided Rectal Cancer Preservation Program

Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study

Latitude

the Efficacy of MR-guided Online Adaptive Radiotherapy for Locally Advanced Rectal Cancer

MERCURY 3

iRECOVER

Knowledge-enhanced Digital Intervention to Prevent Low Anterior Resection Syndrome

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

WASA

PET/MRI in Rectal Cancer

REAL2

Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery

Neoadjuvant Radiochemotherapy Combined With QL1706 for Low Rectal Cancer

A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

SCRIPBOT